About Stellence Pharmscience Private Limited
Data last updated: 23 July 2025
Stellence Pharmscience Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of Avigna Chemitech Private Limited. The company is currently undergoing Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency professional. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 01 January 1992, the company has been in operation for over 34 years.
Registered with ROC Bangalore under CIN U85110KA1992PTC012673.
Capital: an authorised share capital of ₹85 Cr and a paid-up capital of ₹43 Cr. Formerly known as Karnataka Chemsyn Limited and Stellence Pharmscience Limited. It is led by directors including Naveen Kumar Jain and Ramachandran Radhakrishnan.
Last AGM: 30 September 2022. Financial statements filed for year ended 31 March 2022. Office: No.456 1A And 1B Industrial Area Jigani, Bangalore, Karnataka, India – 562106.
As per the financials filed for FY 2022, the company reported a revenue of ₹29.16 Cr, a decline of 16% compared to the previous year.
The company has a workforce of approximately 103 employees as per the latest available data. It operates as a subsidiary of Avigna Chemitech Private Limited.
The company is associated with 2 brands - Stellence Pharmscience, Avigna Pharmaceuticals. As per MCA filings, the company has open charges of ₹38 Cr and satisfied charges of ₹31.92 Cr on record.
The company is undergoing Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency professional, and the company may not be able to independently enter into new commitments. The last known website on record is stellencepharmscience.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered AddressNo.456 1A And 1B Industrial Area Jigani, Bangalore, Karnataka, India – 562106
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Stellence Pharmscience Private Limited
Stellence Pharmscience Private Limited has undergone 2 name changes throughout its history. The company was previously known as Karnataka Chemsyn Limited, and Stellence Pharmscience Limited. The current legal name is Stellence Pharmscience Private Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Stellence Pharmscience Private Limited | Current |
| Karnataka Chemsyn Limited | Previous |
| Stellence Pharmscience Limited | Previous |
CIN History of Stellence Pharmscience Private Limited
Stellence Pharmscience Private Limited has one previous CIN (Corporate Identification Number): U85110KA1992PLC012673. The current CIN is U85110KA1992PTC012673, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85110KA1992PTC012673 | Current |
| U85110KA1992PLC012673 | Previous |
Associated Brands with Stellence Pharmscience Private Limited
Stellence Pharmscience Private Limited operates two associated brands: STELLENCE PHARMSCIENCE and Avigna Pharmaceuticals. These brands represent Stellence Pharmscience Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| An R&D-focused company specializing in manufacturing drugs for various therapeutic areas. | stellencepharmscience.com | |
| Avigna Pharmaceuticals develops and manufactures APIs and specialty chemicals as a contract provider. | avignapharma.com |
Competitors & Alternatives of Stellence Pharmscience Private Limited
Brands and companies operating in the same space as Stellence Pharmscience Private Limited include Laurus Labs, Symbiotec, Beijing Biostar Technologies and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Laurus Labs
|
Pharmaceutical and biotechnology company | Hyderabad, India, India | 2005 |
Symbiotec
|
Non-sterile steroid hormone-based APIs and intermediates are manufactured. | Indore, India, India | 2002 |
Beijing Biostar Technologies
|
APIs, intermediates, and biochemical reagents are developed and manufactured. | Beijing, China, China | 2002 |
Sterling Pharma Solutions
|
Contract development, manufacturing, and analytical services for APIs are offered. | Dudley, United Kingdom, United Kingdom | 2016 |
Provepharm Life Solutions
|
APIs and drug products are developed and valorized in pharmaceuticals. | Marseille, France, France | 1998 |
Hikal
|
APIs and intermediates are produced via custom synthesis and research. | Mumbai, India, India | 1988 |
Snapdragon Chemistry
|
Drug discovery and development service provider | Cambridge, United States, United States | 2014 |
SeQuent
|
APIs are developed and manufactured for therapeutic areas. | Bengaluru, India, India | 2002 |
Jubilant Pharma
|
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | Noida, India, India | 1978 |
Business Activity of Stellence Pharmscience Private Limited
Stellence Pharmscience Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Stellence Pharmscience Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Stellence Pharmscience Private Limited
Stellence Pharmscience Private Limited is audited by P CHANDRASEKAR LLP for the financial year 2022. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| P CHANDRASEKAR LLP | Locked | Locked | Locked |
Complete auditor history for Stellence Pharmscience Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Stellence Pharmscience Private Limited
Stellence Pharmscience Private Limited is currently managed by 5 directors, with 9 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Naveen Kumar Jain
Also directs:
Smartnomics Advisors Llp
|
Irp/Rp/Liquidator | 16 Jul 2024 | 1 Years 11 Months | As last reported |
| Ramachandran Radhakrishnan | Managing Director | 23 Aug 2006 | 19 Years 10 Months | As last reported |
| Anuradha Ramachandran | Director | 15 May 2019 | 7 Years 1 Months | As last reported |
| Akash Mathur | Director | 01 Apr 2020 | 6 Years 3 Months | As last reported |
| Lalit Kumar Yadav | Director | 01 Apr 2020 | 6 Years 3 Months | As last reported |
Financials of Stellence Pharmscience Private Limited FY 2022 filings available
Stellence Pharmscience Private Limited reported revenue of ₹29.16 Cr (down 16.00% YoY) for FY 2022.
Ten-year financial statements for Stellence Pharmscience Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Stellence Pharmscience Private Limited
Shareholding and ownership data for Stellence Pharmscience Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Stellence Pharmscience Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jun 2017 | Tata Capital Financial Services Limited | ₹7.5 Cr | Open |
| 28 Jul 2015 | Religare Finvest Limited | ₹4 Cr | Open |
| 05 May 2015 | Religare Finvest Limited | ₹1.43 Cr | Open |
| 06 Feb 2015 | Religare Finvest Limited | ₹2.92 Cr | Open |
| 05 Sep 2014 | Religare Finvest Limited | ₹20.65 Cr | Open |
Total charge records: 13 View all charges
Employees and EPFO Compliance at Stellence Pharmscience Private Limited
Stellence Pharmscience Private Limited has a workforce of 103 employees as of Apr 06, 2024.
Employee and EPFO history for Stellence Pharmscience Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Stellence Pharmscience Private Limited
GST registrations and filing compliance for Stellence Pharmscience Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Stellence Pharmscience Private Limited
Credit ratings, litigation, and regulatory alerts for Stellence Pharmscience Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Stellence Pharmscience Private Limited
MSME payment history for Stellence Pharmscience Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Stellence Pharmscience Private Limited
Corporate group structure for Stellence Pharmscience Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Stellence Pharmscience Private Limited
MCA filings and documents for Stellence Pharmscience Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Stellence Pharmscience Private Limited
Frequently Asked Questions about Stellence Pharmscience Private Limited
Stellence Pharmscience Private Limited is undergoing "Corporate Insolvency Resolution Process" (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency resolution professional. The company may not be able to independently enter into new commitments during this period. This is a high-risk status - verify the resolution status before any engagement.
Stellence Pharmscience Private Limited is a company under insolvency, formerly operating as a private limited company in the pharma sector based in Bangalore, Karnataka, India. It was incorporated on 01 January 1992 and is registered under CIN U85110KA1992PTC012673. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Stellence Pharmscience Private Limited reported revenue of ₹29.16 Cr for FY 2022 (down 16.00% YoY).
The current directors of Stellence Pharmscience Private Limited are:
- Naveen Kumar Jain - Irp/Rp/Liquidator
- Ramachandran Radhakrishnan - Managing Director
- Anuradha Ramachandran - Director
- Akash Mathur - Director
- Lalit Kumar Yadav - Director
The CIN (Corporate Identification Number) of Stellence Pharmscience Private Limited is U85110KA1992PTC012673. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stellence Pharmscience Private Limited has open charges of ₹38 Cr and satisfied charges of ₹31.92 Cr as per latest MCA filings.